Jennifer Doudna

Extracted Attributes

• Born

  1964-02-19

• Award

  Nobel Prize in Chemistry (2020)

• Known For

  CRISPR-Cas9

• Alma Mater

  Harvard University (Ph.D. in Biochemistry, 1989)

• Occupation

  Professor

• Nationality

  American

• Recognition

  National Inventors Hall of Fame (Inducted 2023)

• Place of Birth

  Washington, D.C., United States

• Current Position

  Adjunct Professor of Cellular and Molecular Pharmacology, University of California, San Francisco (UCSF)

Timeline

• Born in Washington, D.C., United States. (Source: Wikidata, Wikipedia, DBPedia, web search)

  1964-02-19

• Moved with her family to Hilo, Hawaii, where her father accepted a teaching position at the University of Hawaii at Hilo. (Source: web search)

  1971

• Completed her chemistry degree from Pomona College in Claremont, California. (Source: DBPedia, web search)

  1985

• Completed her Ph.D. in biochemistry from Harvard University, under the supervision of Jack W. Szostak. (Source: DBPedia, web search)

  1989

• Appointed assistant professor at Yale University. (Source: web search)

  1994

• Unravelled the structure of the P4-P6 domain of the Tetrahymena thermophila group I intron ribozyme with Thomas Cech. (Source: web search)

  1996-03

• Became an investigator with the Howard Hughes Medical Institute. (Source: Wikipedia, DBPedia, summary)

  1997

• Received the Alan T. Waterman Award for her research on the structure of a ribozyme. (Source: Wikipedia, DBPedia, summary)

  2000

• First proposed, with Emmanuelle Charpentier, that CRISPR-Cas9 could be used for programmable editing of genomes. (Source: Wikipedia, DBPedia, summary, web search)

  2012

• Co-founded the Innovative Genomics Institute. (Source: web search)

  2014

• Named one of Time's 100 most influential people. (Source: Wikipedia, DBPedia, summary)

  2015

• Received the Breakthrough Prize in Life Sciences, shared with Emmanuelle Charpentier, for CRISPR-Cas9 genome editing technology. (Source: Wikipedia, DBPedia, summary)

  2015

• Received the Gruber Prize in Genetics, shared with Emmanuelle Charpentier. (Source: Wikipedia, DBPedia, web search)

  2015

• Received the Tang Prize. (Source: Wikipedia, DBPedia)

  2016

• Received the Canada Gairdner International Award, shared with Emmanuelle Charpentier. (Source: Wikipedia, DBPedia, web search)

  2016

• Received the Japan Prize. (Source: Wikipedia, DBPedia)

  2017

• Awarded the Nobel Prize in Chemistry, shared with Emmanuelle Charpentier, for the development of a method for genome editing. (Source: Wikidata, Wikipedia, DBPedia, summary, web search)

  2020

• Inducted into the National Inventors Hall of Fame. (Source: summary)

  2023

• A new supercomputer named after Doudna was announced for the National Energy Research Scientific Computing. (Source: web search)

  2025

Jennifer Doudna

Jennifer Anne Doudna (; born February 19, 1964) is an American biochemist who has pioneered work in CRISPR gene editing, and made other fundamental contributions in biochemistry and genetics. She received the 2020 Nobel Prize in Chemistry, with Emmanuelle Charpentier, "for the development of a method for genome editing." She is the Li Ka Shing Chancellor's Chair Professor in the department of chemistry and the department of molecular and cell biology at the University of California, Berkeley. She has been an investigator with the Howard Hughes Medical Institute since 1997. In 2012, Doudna and Emmanuelle Charpentier were the first to propose that CRISPR-Cas9 (enzymes from bacteria that control microbial immunity) could be used for programmable editing of genomes, which has been called one of the most significant discoveries in the history of biology. Since then, Doudna has been a leading figure in what is referred to as the "CRISPR revolution" for her fundamental work and leadership in developing CRISPR-mediated genome editing. Doudna's awards and fellowships include the 2000 Alan T. Waterman Award for her research on the structure of a ribozyme, as determined by X-ray crystallography and the 2015 Breakthrough Prize in Life Sciences for CRISPR-Cas9 genome editing technology, with Charpentier. She has been a co-recipient of the Gruber Prize in Genetics (2015), the Tang Prize (2016), the Canada Gairdner International Award (2016), and the Japan Prize (2017). She was named one of the Time 100 most influential people in 2015, and in 2023 was inducted into the National Inventors Hall of Fame. In 2020, Jennifer Doudna was awarded the Nobel Prize in Chemistry alongside Emmanuelle Charpentier for the development of CRISPR-Cas9 genome editing technology, which has revolutionized molecular biology and holds immense potential for treating genetic diseases.

Web Search Results

• Jennifer Doudna | Biography, Facts, & Nobel Prize - Britannica

  Jennifer Doudna (born February 19, 1964, Washington, D.C.) is an American biochemist best known for her discovery, with French microbiologist Emmanuelle Charpentier, of a molecular tool known as clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9. The discovery of CRISPR-Cas9, made in 2012, provided the foundation for gene editing, enabling researchers to make specific changes to DNA sequences in a way that was far more efficient and technically simpler than earlier methods. [...] In addition to receiving the Nobel Prize, Doudna received numerous honors and awards for her research, including the Gruber Prize in Genetics (2015) and the Canada Gairdner International Award (2016), both shared with Charpentier. Doudna was an elected member of multiple academies and a Howard Hughes Medical Institute investigator (from 1997). [...] Doudna spent much of her youth in Hilo, Hawaii. After earning a degree in chemistry in 1985 from Pomona College in California, she went to Harvard University. There she worked in the laboratory of English-born American biochemist and geneticist Jack W. Szostak (who won the 2009 Nobel Prize for Physiology or Medicine) and in 1989 completed a Ph.D. in biochemistry. In 1994, following postdoctoral studies at the University of Colorado under the direction of American biochemist and molecular

• Jennifer A. Doudna - UC Berkeley Research

  Biochemist Jennifer Doudna is best known for her pioneering work in CRISPR gene editing, for which she was awarded the 2020 Nobel Prize in chemistry. She's also a leading biotech entrepreneur, with several life science start-ups under her belt. In a rare interview, Doudna talks about the current work at her Innovative Genomics Institute at the University of California, Berkeley, where scientists are applying genome editing technology to diagnostics, drug discovery, agbiotech and even climate [...] Molecular and cell biology professor Jennifer Doudna, co-inventor of the CRISPR gene editing technology, is leading a team of academic and industry researchers in setting up a testing site for the COVID-19 coronavirus. Using a 2,500-square-foot laboratory, they will serve the Bay Area, processing more than 1,000 samples a day. Later, if the need is there, they hope to be able to process 3,000 a day. "This is a big, big issue here in the U.S.," Professor Doudna says. "We need to ramp up testing [...] UC Berkeley biochemist Jennifer Doudna won the Nobel Prize in chemistry Wednesday for her work helping to develop a genome-editing tool, a breakthrough in biomedicine. Working with colleague Emmanuelle Charpentier, of the Max Planck Institute for Infection Biology in Berlin, Doudna developed CRISPR-Cas9, which allows scientists to edit DNA strands with previously unfathomable precision. For more on this, see our press release at Berkeley News. Stories on this topic have appeared in dozens of

• Jennifer Doudna - Wikipedia

  Jennifer Doudna was born February 19, 1964, in Washington, D.C., as the daughter of Dorothy Jane (Williams) and Martin Kirk Doudna. Her father received his PhD in English literature from the University of Michigan, and her mother held a master's degree in education. When Doudna was seven years old, the family moved to Hawaii so her father could accept a teaching position in American literature at the University of Hawaii at Hilo. Doudna's mother earned a second master's degree in Asian history [...] Doudna was an undergraduate student at Pomona College in Claremont, California, where she studied biochemistry. During her freshman year, while taking a course in general chemistry, she questioned her own ability to pursue a career in science, and considered switching her major to French as a sophomore. However, her French teacher suggested she stay with science. Chemistry professors Fred Grieman and Corwin Hansch at Pomona had a major impact on her. She started her first scientific research in [...] She is also the founder and chair of the governance board of the Innovative Genomics Institute, which she co-founded in 2014.-36) Doudna is also a faculty scientist at Lawrence Berkeley National Laboratory (LBNL), a senior investigator at the Gladstone Institutes, and an adjunct professor of cellular and molecular pharmacology at the University of California, San Francisco (UCSF). In 2025, a new supercomputer named after Doudna was announced for the National Energy Research Scientific Computing

• Professor Jennifer Doudna | Biographical summary

  19 Feb 1964 Jennifer Doudna born Washington, DC, USA 1985 Doudna completed her chemistry degree 1989 Doudna completed her doctorate Oct 1989 RNA demonstrated to help catalyse the process for synthesising protein 1994 Doudna appointed assistant professor at Yale University Mar 1996 Jennifer Doudna and Thomas Cech unravelled structure of P4-P6 domain of the Tetrahymena thermophila group I intron ribozyme, a particular type of RNA 2002 [...] Jennifer Anne Doudna was born in Washington DC. When she was seven years old she moved with her parents to Hilo, a small non-touristy town on the largest island of Hawaii, where her father became a professor in English literature at the University of Hawaii and her mother taught history at a local community college. Landing up in a place where most of the children were of Polynesian and Asian descent and came from a blue-collar background, Doudna always felt slightly out of place with her fair [...] After Pomona College Doudna went to Harvard University where, in 1989, she finished a biochemistry doctorate under the supervision Jack Szostak, a geneticist who would go on to win a Nobel Prize in 2009 for helping to determine how telomeres and the enzyme telomerase protect the chromosome. Her doctoral research focused on ribonucleic acid (RNA). This is a nucleic acid that is a cousin of DNA. It is present in all cells and involved in the synthesis of proteins. Doudna focused her research

• What is CRISPR? - Innovative Genomics Institute (IGI)

  A Crack in Creation takes the reader on a scientific journey, vividly exploring an unexpected discovery that has reshaped the future of humanity. IGI Founder Jennifer Doudna wrote this popular science book about her personal and professional experiences in CRISPR research. Co-authored with her former graduate student, Sam Sternberg, A Crack in Creation offers a behind-the-scenes look at the development of CRISPR genome-editing technology, its applications, and ethical implications. [...] Skip to content Main Logo ## Jennifer Doudna Introduces CRISPR In her first TED Talk back in 2015, IGI Founder Jennifer Doudna gives a great introduction to how the CRISPR-Cas9 system lets scientists edit DNA in almost any kind of cell or organism. This revolutionary genetic engineering tool has created monumental opportunities to cure genetic disease, improve agriculture, and foster a healthy environment — and simultaneously forces us to grapple with difficult ethical dilemmas.

• Award

  Nobel Prize in Chemistry

• Image

  

• Gender

  female

• Educated At

  Harvard University

• Instance Of

  Q5

• Occupation

  chemist

• Citizenship

  United States

• Date Of Birth

  2/19/1964

• Notable Work

  Jennifer Doudna: We can now edit our DNA. But let's do it wisely

• Place Of Birth

  Washington, D.C.

Jennifer Anne Doudna ForMemRS (/ˈdaʊdnə/; born February 19, 1964) is an American biochemist who has done pioneering work in CRISPR gene editing, and made other fundamental contributions in biochemistry and genetics. She received the 2020 Nobel Prize in Chemistry, with Emmanuelle Charpentier, "for the development of a method for genome editing." She is the Li Ka Shing Chancellor's Chair Professor in the Department of Chemistry and the Department of Molecular and Cell Biology at the University of California, Berkeley. She has been an investigator with the Howard Hughes Medical Institute since 1997. She graduated from Pomona College in 1985 and earned a Ph.D. from Harvard Medical School in 1989. Apart from her professorship at Berkeley, she is also president and chair of the board of the Innovative Genomics Institute, a faculty scientist at Lawrence Berkeley National Laboratory, a senior investigator at the Gladstone Institutes, and an adjunct professor of cellular and molecular pharmacology at the University of California, San Francisco (UCSF). In 2012, Doudna and Emmanuelle Charpentier were the first to propose that CRISPR-Cas9 (enzymes from bacteria that control microbial immunity) could be used for programmable editing of genomes, which has been called one of the most significant discoveries in the history of biology. Since then, Doudna has been a leading figure in what is referred to as the "CRISPR revolution" for her fundamental work and leadership in developing CRISPR-mediated genome editing. Her many other prestigious awards and fellowships include the 2000 Alan T. Waterman Award for her research on the structure as determined by X-ray crystallography of a ribozyme, and the 2015 Breakthrough Prize in Life Sciences for CRISPR-Cas9 genome editing technology, with Charpentier. She has been a co-recipient of the Gruber Prize in Genetics (2015), the Tang Prize (2016), the Canada Gairdner International Award (2016), and the Japan Prize (2017). She was named one of the Time 100 most influential people in 2015.